Cargando…
Decreased protein binding of moxifloxacin in patients with sepsis?
The mean (SD) unbound fraction of moxifloxacin in plasma from patients with severe sepsis or septic shock was determined by ultrafiltration to 85.5±3.0% (range 81.9 and 91.6%) indicating a decreased protein binding of moxifloxacin in this population compared with the value of 58–60% provided in the...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
German Medical Science GMS Publishing House
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301732/ https://www.ncbi.nlm.nih.gov/pubmed/30671325 http://dx.doi.org/10.3205/id000029 |
_version_ | 1783381853548314624 |
---|---|
author | Dorn, Christoph Nowak, Hartmuth Weidemann, Caroline Martini, Stefan Zeitlinger, Markus Adamzik, Michael Kees, Frieder |
author_facet | Dorn, Christoph Nowak, Hartmuth Weidemann, Caroline Martini, Stefan Zeitlinger, Markus Adamzik, Michael Kees, Frieder |
author_sort | Dorn, Christoph |
collection | PubMed |
description | The mean (SD) unbound fraction of moxifloxacin in plasma from patients with severe sepsis or septic shock was determined by ultrafiltration to 85.5±3.0% (range 81.9 and 91.6%) indicating a decreased protein binding of moxifloxacin in this population compared with the value of 58–60% provided in the Summary of Product Characteristics. However, previous investigations neglected the influence of pH and temperature on the protein binding of moxifloxacin. Maintaining physiological conditions (pH 7.4, 37°C) – as in the present study – the unbound fraction of moxifloxacin in plasma from healthy volunteers was 84%. In contrast, the unbound fraction of moxifloxacin was 77% at 4°C and 66–68% in unbuffered plasma or at pH 8.5 in fair agreement with previously published data. PK/PD parameters e.g. fAUC/MIC or ratios between interstitial fluid and free plasma concentrations, which were obtained assuming a protein binding rate of moxifloxacin of 40% or more, should be revised. |
format | Online Article Text |
id | pubmed-6301732 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | German Medical Science GMS Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-63017322019-01-22 Decreased protein binding of moxifloxacin in patients with sepsis? Dorn, Christoph Nowak, Hartmuth Weidemann, Caroline Martini, Stefan Zeitlinger, Markus Adamzik, Michael Kees, Frieder GMS Infect Dis Article The mean (SD) unbound fraction of moxifloxacin in plasma from patients with severe sepsis or septic shock was determined by ultrafiltration to 85.5±3.0% (range 81.9 and 91.6%) indicating a decreased protein binding of moxifloxacin in this population compared with the value of 58–60% provided in the Summary of Product Characteristics. However, previous investigations neglected the influence of pH and temperature on the protein binding of moxifloxacin. Maintaining physiological conditions (pH 7.4, 37°C) – as in the present study – the unbound fraction of moxifloxacin in plasma from healthy volunteers was 84%. In contrast, the unbound fraction of moxifloxacin was 77% at 4°C and 66–68% in unbuffered plasma or at pH 8.5 in fair agreement with previously published data. PK/PD parameters e.g. fAUC/MIC or ratios between interstitial fluid and free plasma concentrations, which were obtained assuming a protein binding rate of moxifloxacin of 40% or more, should be revised. German Medical Science GMS Publishing House 2017-02-03 /pmc/articles/PMC6301732/ /pubmed/30671325 http://dx.doi.org/10.3205/id000029 Text en Copyright © 2017 Dorn et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Dorn, Christoph Nowak, Hartmuth Weidemann, Caroline Martini, Stefan Zeitlinger, Markus Adamzik, Michael Kees, Frieder Decreased protein binding of moxifloxacin in patients with sepsis? |
title | Decreased protein binding of moxifloxacin in patients with sepsis? |
title_full | Decreased protein binding of moxifloxacin in patients with sepsis? |
title_fullStr | Decreased protein binding of moxifloxacin in patients with sepsis? |
title_full_unstemmed | Decreased protein binding of moxifloxacin in patients with sepsis? |
title_short | Decreased protein binding of moxifloxacin in patients with sepsis? |
title_sort | decreased protein binding of moxifloxacin in patients with sepsis? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301732/ https://www.ncbi.nlm.nih.gov/pubmed/30671325 http://dx.doi.org/10.3205/id000029 |
work_keys_str_mv | AT dornchristoph decreasedproteinbindingofmoxifloxacininpatientswithsepsis AT nowakhartmuth decreasedproteinbindingofmoxifloxacininpatientswithsepsis AT weidemanncaroline decreasedproteinbindingofmoxifloxacininpatientswithsepsis AT martinistefan decreasedproteinbindingofmoxifloxacininpatientswithsepsis AT zeitlingermarkus decreasedproteinbindingofmoxifloxacininpatientswithsepsis AT adamzikmichael decreasedproteinbindingofmoxifloxacininpatientswithsepsis AT keesfrieder decreasedproteinbindingofmoxifloxacininpatientswithsepsis |